| CONFRONTING
CANCER NOW
An Interactive
Policy Forum on November 12, 2003
Friends of Cancer Research and the Division of United
States Studies at the Woodrow Wilson International Center
for Scholars are collaborating on a unique interactive health
policy forum, “Confronting Cancer Today.” An ensemble
of the foremost cancer experts from scientific and academic
centers, FDA, and industry will gather in Washington D.C.
to present cutting-edge innovations in cancer science and
discuss the processes of translating research to diagnostics,
prevention, and treatment. Senator Ted Stevens,
Senator Arlen Specter and Senator
Ted Kennedy will also speak at the event.
When:
November 12, 2003 from 8:30 A.M. to 12:15 P.M.
Where:
Woodrow Wilson Center’s 6th Floor Auditorium
Ronald Reagan Building, 1300 Pennsylvania Avenue, NW
For directions click here.
Must
RSVP: development@wwic.si.edu or 202.691.4253
The
forum will feature keynote speeches from:
Dr.
Andrew Von Eschenbach, Director of the National
Cancer Institute
Dr. Mark McClellan, Commissioner of the
Food and Drug Administration
Each
speech followed by an hour-long interactive panel Q&A
session moderated by:
Dr.
Charles M. Balch, VP and CEO, American Society
of Clinical Oncologists.
The
first panel, “The Frontier of Cancer Research: Promises
and Challenges,” will focus on the new and emerging
science and highlight current barriers to translating these
advances from the laboratory to the bedside. Panelists include:
Dr.
Nancy Davidson, Professor of Oncology and Breast
Cancer Research Chair in Oncology, Johns Hopkins University
School of Medicine
Dr.
Mel Sorensen, VP, Oncology-MSI, Clinical Development
& Medical Affairs, GlaxoSmithKline
The
Honorable Ralph M. Burnett, Associate Judge, District
Court of Maryland; Board of Directors, National Prostate
Cancer Coalition
The
second panel, “FDA and the Drug Development Process,”
will focus on issues surrounding cancer drug approval within
the FDA with a particular emphasis on the future of cancer
research science. Panelists include:
Dr.
Susan Desmond-Hellman, MPH, Chief Medical Officer
& Executive VP of Development and Product Operation,
Genentech, Inc.
Dr.
Herbert Kim Lyerly, Director, Duke Comprehensive
Cancer Center
Dr.
Gerard Kennealey, VP Clinical Research, Oncology,
AstraZeneca LP
Charlene
G. Wallace, Trinity College Student and Breast
Cancer Survivor
|
